Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cyto Pulse Sciences
Glen Burnie, Maryland, United States
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Clinical-stage medical device company with lead programs in DNA vaccine delivery (notably a colorectal cancer DNA vaccine targeting CEA in Phase 2 trials). The electric field-based PulseAgile platform enabled high-efficiency electroporation for in vivo DNA vaccine delivery and large-scale cell transfection for GMP production.
- Therapeutic areas
- Oncology
- Modalities
- DeviceDNA vaccineTherapeutic vaccine
- Industry
- Biotech
02
Partnerships
Karolinska Institutet (for DNA vaccine programs)
Beyond the preview
Go deeper on Cyto Pulse Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyto Pulse Sciences.